Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Go back to Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates| (NASDAQ: MNPR) | Delayed: 96.47 -6.23 (6.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.70 | 52 Week High | $ | |||
| Open | $102.44 | 52 Week Low | $ | |||
| Day High | $102.45 | P/E | N/A | |||
| Day Low | $95.96 | EPS | $ | |||
| Volume | 382,776 | |||||

